In addition, our relatively comprehensive query of TGF-β pathway polymorphisms and our large population with detailed risk information provide substantial evidence for the involvement of SNPs as predictors or modulators of bladder cancer risk. The gene discussed is TGFB1; the disease is urinary bladder cancer.